Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations

Paediatr Drugs. 2024 Mar;26(2):205-207. doi: 10.1007/s40272-023-00617-3. Epub 2024 Jan 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Ductus Arteriosus, Patent* / drug therapy
  • Humans
  • Ibuprofen* / adverse effects
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Premature

Substances

  • Ibuprofen